Review Article
Volume 7 Issue 4 - 2020
Fundamental Factors of Overweight, Obesity, and Metabolic Syndrome in Cardiovascular Disease (Key Points that Healthcare Providers, Public Health Policymakers, and the General Public Should Know about the CVD-Obesity Connection)
Nicholas A Kerna1*, Uzoamaka Nwokorie2,3, Abdullah Hafid2,3, Emmanuella Solomon2,3 and Priscilla Anusiem2,3
1SMC–Medical Research, Thailand
2University of Health and Humanities, Tortola, BVI
3University of Science, Arts and Technology, Montserrat, BWI
*Corresponding Author: Nicholas A Kerna, POB47 Phatphong, Suriwongse Road, Bangkok, Thailand 10500.
Received: March 17, 2020; Published: March 31, 2020




Abstract

Overweight, obesity, and metabolic syndrome are significant risk factors in developing cardiovascular disease. It would be timeconsuming and a substantial undertaking for most healthcare practitioners (or medical students or residents), to read or review numerous articles to investigate the hallmarks of obesity and the obesity epidemic as they relate to cardiovascular disease and disorders. However, such information is invaluable in coping with cardiovascular disease (as a patient), treating heart patients (as a physician or healthcare provider), or developing public health policies (as a government official, agency, or NGO). Based on an extensive review of the literature on overweight, obesity, and metabolic syndrome, this paper acts as a review, summary, and practical resource, highlighting key points and hallmarks of these risk factors for cardiovascular disease and related disorders.

Keywords: Adiposity; Bariatric; Childhood Obesity; Diabetes; Epigenomics; Metabolic Syndrome; Overweight; Pandemic

References

  1. Carbone S., et al. “Obesity paradox in cardiovascular disease: where do we stand?” Vascular Health and Risk Management 15 (2019): 89-100. https://www.ncbi.nlm.nih.gov/pubmed/31118651 
  2. Khan SS., et al. “Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity”. JAMA Cardiology 3.4 (2018): 280-287. https://www.ncbi.nlm.nih.gov/pubmed/29490333 
  3. Health Risks of Obesity. MedicinePlus, NIH, U.S. National Library of Medicine. https://medlineplus.gov/ency/patientinstructions/000348.htm 
  4. Nuttall FQ. “Body Mass Index, Obesity, BMI, and Health: A Critical Review”. Nutrition Today 50.3 (2015): 117-128. https://www.ncbi.nlm.nih.gov/pubmed/27340299 
  5. O’Neill S and O’Driscoll L. “Metabolic syndrome: A close look at the growing epidemic and its associated pathologies”. Obesity Reviews 16 (2015): 1-12. https://www.ncbi.nlm.nih.gov/pubmed/25407540 
  6. World Health Organization (WHO) (2015). http://www.who.int/mediacentre/factsheets/fs311/en/ 
  7. World Resources Institute (WRI) (2015). http://www.wri.org/our-work/topics/food 
  8. Jeffery RW and Utter J. “The changing environment and population obesity in the United States”. Obesity Research 11 (2003): 12S-22S. https://onlinelibrary.wiley.com/doi/full/10.1038/oby.2003.221
  9. Centers for Disease Control and Prevention (CDC). Childhood overweight and obesity.[Division of Nutrition, Physical Activity, and Obesity (2015). http://www.cdc.gov/obesity/childhood/ 
  10. Ostbye T., et al. “Obesity and Workers' Compensation: Results from the Duke Health and Safety Surveillance System”. Archives of Internal Medicine 167.8 (2007): 766-773. https://www.ncbi.nlm.nih.gov/pubmed/17452538 
  11. The Guardian. Severe obesity is a disability, European court adviser rules (2014). https://www.theguardian.com/law/2014/jul/17/obesity-disability-european-court-discrimination-claim 
  12. McAllister EJ., et al. “Ten Putative Contributors to the Obesity Epidemic”. Critical Reviews in Food Science and Nutrition 49.10 (2009): 868-913. https://www.ncbi.nlm.nih.gov/pubmed/19960394
  13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders”. 5th edition. Arlington, Va, USA: American Psychiatric Press (2013). 
  14. Styne DM., et al. “Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline”. The Journal of Clinical Endocrinology and Metabolism 102.3-1 (2017): 709-757. https://www.ncbi.nlm.nih.gov/pubmed/28359099
  15. Williamson DF., et al. “Smoking Cessation and Severity of Weight Gain in a National Cohort”. The New England Journal of Medicine 324 (1991): 739-745. https://www.ncbi.nlm.nih.gov/pubmed/1997840
  16. Wadden T.A., et al. “A two-year randomized trial of obesity treatment in primary care practice”. The New England Journal of Medicine 36.21 (2011): 1969-1979. https://www.nejm.org/doi/full/10.1056/NEJMoa1109220 
  17. Esteve E., et al. “Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiota co-evolve with insulin resistance?” Current Opinion in Clinical Nutrition and Metabolic Care: 14.5 (2011): 483-490. https://europepmc.org/article/med/21681087 
  18. Crowley VE., et al. “Obesity therapy: altering the energy intake-and-expenditure balance sheet”. Nature Reviews Drug Discovery 1.4 (2002): 276-286. https://www.nature.com/articles/nrd770
  19. Rosamond W., et al. “Heart Diseases and Stroke Statistics - 2008 Update”. Circulation 117 (2008): e25-e146. https://www.ncbi.nlm.nih.gov/pubmed/18086926 
  20. World Health Organization (WHO). (2008-2013) Action plan for global strategic for prevention and control of noncommunicable diseases (2015). 
  21. Jensen MD., et al. “AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society”. Circulation 129.2 (2013): S102-S138. https://www.ahajournals.org/doi/full/10.1161/01.cir.0000437739.71477.ee
  22. Barlow S and Expert Committee. “Expert committee recommendations regarding prevention, assessment, and treatment of child and adolescent overweight and obesity: Summary report”. Pediatrics 120.4 (2007): S164-S192. https://www.ncbi.nlm.nih.gov/pubmed/18055651
  23. Rueda-Clausen CF., et al. “New pharmacological approaches for obesity management”. Nature Reviews Endocrinology 9 (2013): 467-478. https://www.ncbi.nlm.nih.gov/pubmed/23752772
  24. Calderon-Larranaga, A., et al. “Multimorbidity and weight loss in obese primary care patients: Longitudinal study based on electronic health records”. British Medical Journal Open 5.3 (2015): 1-9. https://bmjopen.bmj.com/content/5/3/e006227 
  25. Mechanick JI., et al. “American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine”. Endocrine Practice 18 (2012): 642-648. https://www.ncbi.nlm.nih.gov/pubmed/23047927 
  26. Pasarica M and Topping D. “An evidence-based approach to teaching obesity management to medical students”. MedEd PORTAL 13 (2017): 10662. https://www.ncbi.nlm.nih.gov/pubmed/30800862 
  27. Centers for Disease Control and Prevention (CDC) (2014). http://www.cdc.gov/obesity/data/adult.html 
  28. Centers for Disease Control and Prevention (CDC). Adult obesity: Obesity rises among adults. [National Center for Chronic Disease Prevention and Health Promotion: Division of Nutrition, Physical Activity and Obesity]. CDC Vital signs (2010). http://www.cdc.gov/obesity/data/prevalence-maps.html 
  29. McAllister EJ., et al. “Ten Putative Contributors to the Obesity Epidemic”. Critical Reviews in Food Science and Nutrition 49.10 (2009): 868-913. https://www.ncbi.nlm.nih.gov/pubmed/19960394
  30. Leroux JS., et al. “Beyond the “I” in the Obesity Epidemic: A Review of Social Relational and Network Interventions on Obesity”. International Journal of Obesity (2013): 1-10. https://www.hindawi.com/journals/jobe/2013/348249/
  31. Flegal KM., et al. “Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis”. Journal of the American Medical Association 309.1 (2013): 71-82. https://www.ncbi.nlm.nih.gov/pubmed/23280227 
  32. US Department of Health and Human Services. “The Surgeon General's call to action to prevent and decrease overweight and obesity”. Report (2001). https://www.ncbi.nlm.nih.gov/books/NBK44206/ 
  33. Thompson D., et al. “Lifetime health and economic consequences of obesity”. Archives of Internal Medicine 159.18 (1999): 2177-2183. https://www.ncbi.nlm.nih.gov/pubmed/10527295
  34. Wang YC., et al. “Health and economic burden of the projected obesity trends in the USA and the UK”. Lancet 378 (2011): 815-825. https://www.ncbi.nlm.nih.gov/pubmed/21872750
  35. Pollack A. “AMA Recognizes Obesity as a Disease. NYTimescom (2013). http://nyti.ms/1Guko03 
  36. WHO Obesity and overweight. WHO (2014). http://www.who.int/mediacentre/factsheets/fs311/en/ 
  37. Barquera S., et al. “Cardiovascular diseases in mega-countries: the challenges of the nutrition, physical activity and epidemiologic transitions, and the double burden of disease”. Current opinion in lipidology 27.4 (2016): 329-344. https://www.ncbi.nlm.nih.gov/pubmed/27389629 
  38. David BA., et al. “Antipsychotic‐induced weight gain: A comprehensive research synthesis”. The American Journal of Psychiatry 156 (1999): 1686-1696. https://www.ncbi.nlm.nih.gov/pubmed/10553730 
  39. Masand PS. “Weight gain associated with psychotropic drugs”. Expert Opinion on Pharmacotherapy 1 (2000): 377-373. https://www.ncbi.nlm.nih.gov/pubmed/11249524 
  40. Pijl H and Meinders AE. “Body weight changes as an adverse effect of drug treatment. Mechanisms and management”. Drug Safety 14 (1996): 329-342. https://www.ncbi.nlm.nih.gov/pubmed/8800628 
  41. Nasrallah H. “A review of the effect of atypical antipsychotics in weight”. Psychoneuroendocrinology 28 (2003): 83-99. https://www.ncbi.nlm.nih.gov/pubmed/12504074
  42. Avena NM., et al. “Further developments in the neurobiology of food and addiction: Update on the state of the science”. Nutrition 28 (2012): 341-343. https://www.ncbi.nlm.nih.gov/pubmed/22305533 
  43. Davis C and Carter JC. “Compulsive overeating as an addiction disorder. A review of theory and evidence”. Appetite 53 (2009): 1-8. https://www.ncbi.nlm.nih.gov/pubmed/19500625 
  44. Lobstein T., et al. “Child and adolescent obesity: part of a bigger picture”. Lancet 385 (2015): 2510-2520. https://www.ncbi.nlm.nih.gov/pubmed/25703114
  45. Lobstein T., et al. “Obesity in children and young people: a crisis in public health”. Obesity Reviews 5 (2004): 4-85. https://www.ncbi.nlm.nih.gov/pubmed/15096099
  46. Abdullah A., et al. “The number of years lived with obesity and the risk of all-cause and cause-specific mortality”. International Journal of Epidemiology 40 (2011): 985-996. https://academic.oup.com/ije/article/40/4/985/681646
  47. Schwartz MW., et al. “Obesity pathogenesis: an endocrine society scientific statement”. Endocrine Reviews 38.4 (2017): 267-296. https://www.ncbi.nlm.nih.gov/pubmed/28898979
  48. Poirier P. “Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 american heart association scientific statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism”. Circulation 113.6 (2006): 898-918. https://www.ncbi.nlm.nih.gov/pubmed/16380542
  49. Litwin SE. “Which measures of obesity best predict cardiovascular risk? ” Journal of the American College of Cardiology 52.8 (2008): 616-619. https://www.ncbi.nlm.nih.gov/pubmed/18702963
  50. Cook S., et al. “Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice”. Swiss Medical Weekly 133 (2003): 360-363. https://www.ncbi.nlm.nih.gov/pubmed/12947532
  51. Bosy-Westphal A., et al. “Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study”. International Journal of Obesity 31 (2007): 784-790. https://www.ncbi.nlm.nih.gov/pubmed/17047637 
  52. Hong Y., et al. “Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality-results of prospective analysis for the Atherosclerosis Risk in Communities study”. Journal of Internal Medicine 262 (2007): 113-122. https://www.ncbi.nlm.nih.gov/pubmed/17598819 
  53. WHO. Global Strategy on Diet, Physical Activity and Health (2020).
  54. Hill JO and Melanson EL. “Overview of the determinants of overweight and obesity: current evidence and research issues”. Medicine and Science in Sports and Exercise 31 (1999): 515-521. https://www.ncbi.nlm.nih.gov/pubmed/10593521
  55. Nisbett RE. “Determinants of food intake in human obesity”. Science 159 (1968): 1254-1255. https://www.ncbi.nlm.nih.gov/pubmed/5711760
  56. Peters JC., et al. “From instinct to intellect: the challenge of maintaining healthy weight in the modern world”. Obesity Reviews 3 (2002): 69-74. https://www.ncbi.nlm.nih.gov/pubmed/12120422
  57. Perri MG and Corsica JA. “Improving the maintenance of weight lost in behavioral treatment of obesity”. In: Wadden TA, Stunkard AJ, eds. Handbook of Obesity Treatment. New York: Guilford (2002): 357-379.
  58. Stunkard AJ., et al. “Energy intake, not energy output, is a determinant of body size in infants”. The American Journal of Clinical Nutrition 69 (1999): 524-530. https://www.sciencedirect.com/science/article/abs/pii/S089085670963255X
  59. Brownell KD. “The central role of lifestyle change in longterm weight management”. Clinical Cornerstone 2 (1999): 43-51. https://www.ncbi.nlm.nih.gov/pubmed/10696284
  60. Wadden TA., et al. “Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial”. Archives of Internal Medicine 161 (2001): 218-227. https://www.ncbi.nlm.nih.gov/pubmed/11176735
  61. Olshansky SJ., et al. “A potential decline in life expectancy in the United States in the 21st century”. The New England Journal of Medicine 352.11 (2005): 1138-1145. https://www.ncbi.nlm.nih.gov/pubmed/15784668 
  62. Committee on Accelerating Progress in Obesity Prevention. “Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation”. National Academies Press (2012). https://www.ncbi.nlm.nih.gov/pubmed/24830053 
  63. Barlow SE., et al. “Medical evaluation of overweight children and adolescents: reports from pediatricians, pediatric nurse practitioners, and registered dietitians”. Pediatrics 110.1 (2002): 222-228. https://www.ncbi.nlm.nih.gov/pubmed/12093999
  64. Galuska D., et al. “Are health care professionals advising obese patients to lose weight? ” Journal of the American Medical Association 282 (1999): 1576-1578. https://www.ncbi.nlm.nih.gov/pubmed/10546698 
  65. Yeh HC., et al. “Independent but coordinated trials: insights from the Practice-based Opportunities for Weight Reduction Trials Collaborative Research Group”. Clinical Trial 7 (2010): 322-332. https://www.ncbi.nlm.nih.gov/pubmed/20573639 
  66. Wadden TA., et al. “A two-year randomized trial of obesity treatment in primary care practice”. The New England Journal of Medicine 365 (2011): 1969-1979. https://www.nejm.org/doi/full/10.1056/NEJMoa1109220 
  67. Appel LJ., et al. “Comparative effectiveness of weight-loss interventions in clinical practice”. The New England Journal of Medicine 365 (2011): 1959-1968. https://www.researchgate.net/publication/51801052_Comparative_Effectiveness_of_Weight-Loss_Interventions_in_Clinical_Practice 
  68. Bennett GG., et al. “Obesity treatment for socioeconomically disadvantaged patients in primary care practice”. Archives of Internal Medicine 172 (2012): 565-574. https://www.ncbi.nlm.nih.gov/pubmed/22412073 
  69. Moyer VA. “Services Task Force Screening for and management of obesity in adults. U.S. Preventive Services Task Force recommendation statement”. Annals of Internal Medicine 157 (2012): 373-378. https://www.ncbi.nlm.nih.gov/pubmed/22733087 
  70. Centers for Medicare and Medicaid Services. Decision memo for intensive behavioral therapy for obesity (CAG-00423N) (2012). https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=253 
  71. Malik VS., et al. “Global obesity: trends, risk factors and policy implications”. Nature Reviews Endocrinology 9.1 (2013): 13-27. https://www.ncbi.nlm.nih.gov/pubmed/23165161 
  72. Sainsbury A and Hay P. “Call for an urgent rethink of the ‘health at every size’ concept”. International Journal of Eating Disorders 2 (2014): 8. https://www.ncbi.nlm.nih.gov/pubmed/24764532 
  73. Hurt R., et al. “The Obesity Epidemic: Challenges, Health Initiatives, and Implications for Gastroenterologists”. Gastroenterology and Hepatology 6.12 (2010): 780-792. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033553/
  74. Nichols M., et al. “European Cardiovascular Disease Statistics. European Cardiovascular Disease Statistics 2012 edition”. Brussels, Belgium: European Heart Network AISBL (2012). https://www.escardio.org/static_file/Escardio/Press-media/press-releases/2013/EU-cardiovascular-disease-statistics-2012.pdf
Citation: Nicholas A Kerna., et al. “Fundamental Factors of Overweight, Obesity, and Metabolic Syndrome in Cardiovascular Disease (Key Points that Healthcare Providers, Public Health Policymakers, and the General Public Should Know about the CVD-Obesity Connection)”. EC Cardiology 7.4 (2020): 45-54.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


June Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the June issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before June 25, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk